Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SclerFIX-IP in PIP Joint Osteoarthritis
NCT06034262Phase 2Terminated
- Sponsor
- TBF Génie Tissulaire
- Start
- Oct 2024
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in hand osteoarthritis, sponsored by TBF Génie Tissulaire. Primary endpoint: Change in the symptomatology related to the PIPJ OA at 12 months. Started Oct 2024; status: terminated.
02
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on NCT06034262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06034262.